Sims Andrew John Hugh MacIntyre
Known title: Chief Financial OfficerCIK: 0001802687
Sims Andrew John Hugh MacIntyre's purchase track record
Sims Andrew John Hugh MacIntyre has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/4/2025 | CNSY | $10K | pending | pending | — |
| 9/10/2024 | CNSY | $5K | pending | pending | — |
| 5/8/2024 | CNSY | $10K | pending | pending | — |
| 4/26/2022 | CNSY | $2K | pending | pending | — |
| 3/1/2022 | CNSY | $2K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CNSY | ▲ Buy | Option Exercise | 1,533 | $0 | 10/1/2026 | View on chart |
| CNSY | ▲ Buy | Option Exercise | 1,165 | $0 | 10/1/2026 | View on chart |
| CNSY | ▲ Buy | Option Exercise | 287 | $0 | 10/1/2026 | View on chart |
| CNSY | ▲ Buy | Option Exercise | 1,533 | $0 | 7/1/2026 | View on chart |
| CNSY | ▲ Buy | Option Exercise | 1,165 | $0 | 7/1/2026 | View on chart |
| CNSY | ▲ Buy | Option Exercise | 287 | $0 | 7/1/2026 | View on chart |
| CNSY | ▲ Buy | Option Exercise | 38,323 | $0 | 4/1/2026 | View on chart |
| CNSY | ▲ Buy | Option Exercise | 29,129 | $0 | 4/1/2026 | View on chart |
| CNSY | ▲ Buy | Option Exercise | 38,323 | $0 | 1/1/2026 | View on chart |
| CNSY | ▲ Buy | Open Market | 20,000 | $10K | 11/4/2025 | View on chart |
| CNSY | ▲ Buy | Option Exercise | 38,323 | $0 | 10/1/2025 | View on chart |
| CNSY | ▲ Buy | Open Market | 4,098 | $5K | 9/10/2024 | View on chart |
| CNSY | ▲ Buy | Open Market | 4,902 | $10K | 5/8/2024 | View on chart |
| CNSY | ▲ Buy | Open Market | 3,000 | $2K | 4/26/2022 | View on chart |
| CNSY | ▲ Buy | Open Market | 2,000 | $2K | 3/1/2022 | View on chart |
| CNSY | ▲ Buy | Open Market | 1,000 | $2K | 11/2/2021 | View on chart |
| CNSY | ▲ Buy | Open Market | 2,000 | $3K | 10/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Cerenome projects $1.55M in Q3 CNSide billings
Cerenome expects $1.55 million in gross billings for its CNSide platform in the third quarter. The company also announced it will hold a business update call on September 30, 2026, to discuss progress in its diagnostic division. This update provides specific revenue expectations for the company's main product line.
Cerenome projects $1.55M in Q3 CNSide billings. Cerenome expects $1.55 million in gross billings for its CNSide platform in the third quarter. The company also announced it will hold a business update call on September 30, 2026, to discuss progress in its diagnostic division. This update provides specific revenue expectations for the company's main product line.